Ethylmalonic acid

Ethylmalonic acid is a lipid of Fatty Acyls (FA) class. Ethylmalonic acid is associated with abnormalities such as Petechiae and Metabolic Diseases. The involved functions are known as Oxidation, Catabolic Process, Excretory function and Acidemia. Ethylmalonic acid often locates in Mitochondria. The associated genes with Ethylmalonic acid are N-caproylglycine and ETHE1 gene. The related lipids are Fatty Acids and sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Ethylmalonic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ethylmalonic acid?

Ethylmalonic acid is suspected in Petechiae, Metabolic Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ethylmalonic acid

MeSH term MeSH ID Detail
Brain Diseases D001927 27 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Leukocytosis D007964 9 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Glomerulonephritis D005921 35 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Vomiting D014839 21 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Per page 10 20 | Total 14

PubChem Associated disorders and diseases

What pathways are associated with Ethylmalonic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Ethylmalonic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ethylmalonic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ethylmalonic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ethylmalonic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ethylmalonic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ethylmalonic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Ethylmalonic acid

Download all related citations
Per page 10 20 50 100 | Total 119
Authors Title Published Journal PubMed Link
Herdman MT et al. The role of previously unmeasured organic acids in the pathogenesis of severe malaria. 2015 Crit Care pmid:26343146
Pavlou E et al. An infant with ethylmalonic encephalopathy masquerading as a hematologic disorder. 2013 J. Child Neurol. pmid:22805253
Schuck PF et al. Ethylmalonic acid modulates Na+, K(+)-ATPase activity and mRNA levels in rat cerebral cortex. 2013 Synapse pmid:23161776
Amaral AU et al. Ethylmalonic acid impairs brain mitochondrial succinate and malate transport. 2012 Mol. Genet. Metab. pmid:22133302
Dweikat I et al. Ethylmalonic encephalopathy associated with crescentic glomerulonephritis. 2012 Metab Brain Dis pmid:22584649
Gallant NM et al. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. 2012 Mol. Genet. Metab. pmid:22424739
Tomlinson L et al. Cannabinoid receptor antagonist-induced striated muscle toxicity and ethylmalonic-adipic aciduria in beagle dogs. 2012 Toxicol. Sci. pmid:22821849
Schmidt SP et al. Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase. 2011 J. Inherit. Metab. Dis. pmid:21170680
Westermann CM et al. Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. 2011 Mol. Genet. Metab. pmid:21843962
Linster CL et al. Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading. 2011 J. Biol. Chem. pmid:22016388
Zolkipli Z et al. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants. 2011 PLoS ONE pmid:21483766
Rodenburg RJ Biochemical diagnosis of mitochondrial disorders. 2011 J. Inherit. Metab. Dis. pmid:20440652
Bosch AM et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. 2011 J. Inherit. Metab. Dis. pmid:21110228
Barth M et al. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. 2010 J. Inherit. Metab. Dis. pmid:20978941
Schuck PF et al. Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. 2010 Neurochem. Res. pmid:19757035
van Maldegem BT et al. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. 2010 Pediatr. Res. pmid:19952864
Pedersen CB et al. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. 2010 J. Inherit. Metab. Dis. pmid:20443061
Viscomi C et al. Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. 2010 Nat. Med. pmid:20657580
Zannolli R et al. Silent increase of urinary ethylmalonic acid is an indicator of nonspecific brain dysfunction. 2010 NMR Biomed pmid:20187168
van Maldegem BT et al. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. 2010 J. Inherit. Metab. Dis. pmid:20429031
Chae JH et al. Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect. 2010 Korean J Pediatr pmid:21253313
DiMauro S Pathogenesis and treatment of mitochondrial myopathies: recent advances. 2010 Acta Myol pmid:21314015
Skovran E et al. A systems biology approach uncovers cellular strategies used by Methylobacterium extorquens AM1 during the switch from multi- to single-carbon growth. 2010 PLoS ONE pmid:21124828
Das AM et al. Inborn errors of energy metabolism associated with myopathies. 2010 J. Biomed. Biotechnol. pmid:20589068
Doboszewski B et al. 6-[Bis(ethoxycarbonyl)methyl]-6-deoxy-1,2;3,4-di-O-isopropyl-idene-d-galacto-pyran-ose. 2010 Acta Crystallogr Sect E Struct Rep Online pmid:21589509
Takei M et al. Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family. 2010 Toxicol. Sci. pmid:20616209
Schuck PF et al. Chronic early postnatal administration of ethylmalonic acid to rats causes behavioral deficit. 2009 Behav. Brain Res. pmid:18950661
Tiranti V et al. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. 2009 Nat. Med. pmid:19136963
Okuyaz C et al. Severe infantile hypotonia with ethylmalonic aciduria: case report. 2008 J. Child Neurol. pmid:18539996
Pedersen CB et al. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. 2008 Hum. Genet. pmid:18523805
Westermann CM et al. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. 2008 Neuromuscul. Disord. pmid:18406615
Plecko B Lessons to learn from rare inborn errors of metabolism. 2007 Neuropediatrics pmid:17712731
Zafeiriou DI et al. Ethylmalonic encephalopathy: clinical and biochemical observations. 2007 Neuropediatrics pmid:17712735
Bross P et al. Single-nucleotide variations in the genes encoding the mitochondrial Hsp60/Hsp10 chaperone system and their disease-causing potential. 2007 J. Hum. Genet. pmid:17072495
Heberle LC et al. Ethylmalonic encephalopathy-report of two cases. 2006 Brain Dev. pmid:16376514
Merinero B et al. Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. 2006 J. Inherit. Metab. Dis. pmid:16906473
van Maldegem BT et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. 2006 JAMA pmid:16926354
Di Rocco M et al. A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation. 2006 Mol. Genet. Metab. pmid:16828325
Barschak AG et al. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. 2006 Metab Brain Dis pmid:16773466
Ferreira Gda C et al. Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues. 2006 Metab Brain Dis pmid:16773468
Tiranti V et al. ETHE1 mutations are specific to ethylmalonic encephalopathy. 2006 J. Med. Genet. pmid:16183799
Gordon N Acyl-CoA dehydrogenase deficiency: varieties with neurological involvement. 2005 Dev Med Child Neurol pmid:15739728
Read MH et al. Clinical, biochemical, magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H MRS) findings in a fourth case of combined D- and L-2 hydroxyglutaric aciduria. 2005 J. Inherit. Metab. Dis. pmid:16435212
Rinaldo P et al. Recent developments and new applications of tandem mass spectrometry in newborn screening. 2004 Curr. Opin. Pediatr. pmid:15273505
Tiranti V et al. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. 2004 Am. J. Hum. Genet. pmid:14732903
McGowan KA et al. The role of methionine in ethylmalonic encephalopathy with petechiae. 2004 Arch. Neurol. pmid:15096407
Leipnitz G et al. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. 2003 Neurochem. Res. pmid:12716029
Seidel J et al. Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase gene. 2003 J. Inherit. Metab. Dis. pmid:12872838
Fu X et al. Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes. 2003 J. Inherit. Metab. Dis. pmid:12872841
Liang Y et al. [Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II)]. 2003 Zhonghua Er Ke Za Zhi pmid:14723814